Chabrier, P E <br/><br/>
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.  [electronic resource] 

 -  Cellular and molecular life sciences : CMLS  Jul 1999 
 - 1029-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1420-682X 
<br/><br/><label>Standard No.: </label>10.1007/s000180050353  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amidines--pharmacology<br/>Amyotrophic Lateral Sclerosis--drug therapy<br/>Animals<br/>Benzylamines--pharmacology<br/>Brain Injuries--drug therapy<br/>Brain Ischemia--drug therapy<br/>Enzyme Induction<br/>Humans<br/>Huntington Disease--drug therapy<br/>Mice<br/>Mice, Neurologic Mutants<br/>Mice, Transgenic<br/>Nerve Degeneration--drug therapy<br/>Nerve Tissue Proteins--antagonists & inhibitors<br/>Nervous System Diseases--drug therapy<br/>Nitric Oxide--adverse effects<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Nitric Oxide Synthase Type I<br/>Organ Specificity<br/>Polymethacrylic Acids--pharmacology<br/>Pyrazines--pharmacology<br/>Thiophenes--pharmacology